Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

LY-2608204

Generic Name: LY-2608204

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₃₇N_₃O_₃S_₃

CAS Number: 1234703-40-2

Unique Ingredient Identifier: 5A0L003HEY

Overview

LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Background

LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus

Phase 2

Completed

Posted: 2020/01/03

Sponsor:

Suzhou Yabao Pharmac...

ID:NCT04217291

Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus

Phase 1

Completed

Posted: 2018/01/30

Sponsor:

Yabao Pharmaceutical...

ID:NCT03414892

The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydrochloride

Phase 1

Completed

Posted: 2017/05/31

Sponsor:

Yabao Pharmaceutical...

ID:NCT03171623

A Study in Patients With Type 2 Diabetes

Phase 2

Withdrawn

Posted: 2011/08/03

Sponsor:Eli Lilly and Compan...

ID:NCT01408095

A Study of LY2608204 in Patients With Type 2 Diabetes

Phase 1

Completed

Posted: 2010/11/24

Sponsor:Eli Lilly and Compan...

ID:NCT01247363

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy